Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Q8003 in Postoperative Pain
NCT00818493Phase 2Completed
- Sponsor
- QRxPharma Limited
- Start
- Feb 2009
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of moxifloxacin + ibuprofen in postoperative pain (3 arms), sponsored by QRxPharma Limited. Primary endpoint: Difference in pain intensity scores from baseline at 48 hours. Started Feb 2009; status: completed.
02
Drugs
moxifloxacin + ibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00818493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00818493.